The healthcare industry as we know it today will be unrecognizable a decade from now…
Several technological breakthroughs are coming together to upend one of the largest industries in the world. And one of the biggest culprits is artificial intelligence (AI).
On today’s episode of the SteadyTrade Podcast, Tim Bohen and Matt McCall dive into some of the biggest implications that AI will have on the future of the healthcare industry.
It currently takes about 10 years and more than $1 billion to take a drug from the discovery phase to full FDA approval. That is incredibly costly and timely. But what makes the process even worse is that only about one in 10 potential drugs make it all the way through that cycle.
Think about all the data that’s created throughout the drug discovery process…
That makes it the perfect niche sector to be disrupted by the power of AI.
On the podcast, Tim and Matt share their big-picture thoughts regarding where we are in the AI-drug discovery stocks cycle and where the opportunities lie today. Several small companies are working to meld AI with the current drug-discovery process, and you can be sure they give you a few names to add to your watch list.